Skip to main content
Equibles
BNTC logo

BNTC · Benitec Biopharma Inc. · Metrics

Track BNTC — free

Use BNTC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BNTC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$12.19 -0.03 (-0.25%) At close · Sep 11
Russell 2000 member Rebalance outlook locked
Market Cap
$418.78M
Shares
34.35M

BNTC metrics

58 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$12.19
Market cap
$418.78M

Price action

20 metrics
Price change (1W)
-1.8%
Price change (30D)
-2.7%
Price change (3M)
+10.6%
Price change (6M)
+0.8%
Price change (YTD)
-9.3%
Price change (1Y)
-8.4%
Trailing year
Price change (5Y)
—
52-week high
$16.52
52-week low
$10.06
Change from 52-week high
-26.0%
Change from 52-week low
+21.5%
Annualized volatility
58.2%
Annualized volatility (3M)
51.3%
Beta
1.4
RSI (14D)
44.9
Price vs SMA 50
-3.5%
Price vs SMA 200
+1.1%
Avg volume (3M)
142,426
Relative volume
0.7
Average dollar volume
$1.79M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
34.35M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
2.3
reciprocal yield 43.8%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-9.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-05-14

Profitability

9 metrics
Gross margin
—
Operating margin
—
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
−$46.60M
Net income (TTM)
−$41.54M
Trailing 12 months
Diluted EPS (TTM)
$-0.93
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-1.04
EBITDA per diluted share (TTM)
$-1.04
Net income per diluted share (TTM)
$-0.93
Operating cash flow per diluted share (TTM)
$-0.45
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
$0.41
Stock compensation per diluted share (TTM)
$0.59
Book value per share
$3.71

Growth

11 metrics
Revenue growth YoY
-100.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$0
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+27.9%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-22.7%
Return on assets
-22.2%
Debt / equity
—
Current ratio
56.8
EBITDA (TTM)
−$46.54M
Free cash flow (TTM)
—
Quick ratio
56.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$184.76M
Latest balance sheet
Cash & equivalents
$184.76M
Total assets
$187.00M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$19.79M
Capital expenditures (TTM)
$26,000
R&D (TTM)
$18.37M
SG&A (TTM)
—
Stock compensation (TTM)
$26.26M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
86
13F filer change QoQ
-2
Institutional ownership
96.5%

Short interest

3 metrics
Short interest
6.4%
Latest settlement · 14.3 days to cover
Days to cover
14.3d
Short-squeeze score
76 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1808898 CUSIP 08205P209 13F (30d) 52 filings 52 filers Visit website Investor relations